Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage
about
HIV treatment-as-prevention research at a crossroadsAntiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia.The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials.CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study.Human Resources for Treating HIV/AIDS: Are the Preventive Effects of Antiretroviral Treatment a Game Changer?Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database.Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South AfricaCD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.Development of a clinical scoring system for assessment of immunosuppression in patients with tuberculosis and HIV infection without access to CD4 cell testing--results from a cross-sectional study in Ethiopia.A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus/acquired immune deficiency syndrome.Risk indicators and effects of hypertension on HIV/AIDS disease progression among patients seen at Kenyatta hospital HIV care center.Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.Lymphoid tissue fibrosis is associated with impaired vaccine responses.
P2860
Q21144591-1DCEE29B-3984-455A-BE2B-29C670CE0DEDQ33783987-61EED66C-AC87-4301-9115-21DAD6A618CEQ33909241-1234E224-01BD-4DF6-80A7-FE4D0E36F003Q34418077-6003DE6A-D006-41C5-8A1F-BA4707A4FD64Q35225198-52FECDDC-7E15-4B0F-9271-211F2CB8CCF4Q36157634-4AC94447-7E4D-49CF-ABBF-5C7FFC6097EAQ36157659-D49FDC5E-28C1-4637-90A4-349787539282Q36380146-922B8BC7-1347-4C70-A117-E6FE09E2F1F8Q37220730-9D58C6FB-60B0-4FDC-8319-90D2B85E2AF3Q37587141-6C7E9697-056D-473B-8AD8-FFFB53F9661AQ41490253-D90F69E8-28BC-45C8-A3F1-5CF91D478388Q41989788-00188E3D-C6B2-47C6-B210-153CC71FEEFDQ52676754-9F470701-344D-4FFB-B06B-076700C7A964Q54204593-23B61626-156E-4BEE-BF8C-5149D858EA88
P2860
Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Population-based CD4 counts in ...... iretroviral treatment coverage
@ast
Population-based CD4 counts in ...... iretroviral treatment coverage
@en
Population-based CD4 counts in ...... iretroviral treatment coverage
@nl
type
label
Population-based CD4 counts in ...... iretroviral treatment coverage
@ast
Population-based CD4 counts in ...... iretroviral treatment coverage
@en
Population-based CD4 counts in ...... iretroviral treatment coverage
@nl
prefLabel
Population-based CD4 counts in ...... iretroviral treatment coverage
@ast
Population-based CD4 counts in ...... iretroviral treatment coverage
@en
Population-based CD4 counts in ...... iretroviral treatment coverage
@nl
P2860
P50
P1433
P1476
Population-based CD4 counts in ...... iretroviral treatment coverage
@en
P2093
Abraham Malaza
Johannes Viljoen
P2860
P304
P356
10.1371/JOURNAL.PONE.0070126
P407
P577
2013-07-23T00:00:00Z